Hand Sanitizer Guidance Extension Act of 2020 This bill specifies that certain Food and Drug Administration guidance related to the manufacture of alcohol-based hand sanitizers during the COVID-19 (i.e., coronavirus disease 2019) public health emergency shall remain in effect for two years after this bill's enactment. The bill also imposes various requirements related to the content of hand sanitizers manufactured while the guidance is in effect.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2934-2935; text: CR S2934)
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2934-2935; text: CR S2934)
Health
Cardiovascular and respiratory healthDrug safety, medical device, and laboratory regulationEmergency medical services and trauma careHazardous wastes and toxic substancesHealth promotion and preventive careHealth technology, devices, suppliesInfectious and parasitic diseasesManufacturingMotor fuels
Hand Sanitizer Guidance Extension Act of 2020
USA116th CongressS-3938| Senate
| Updated: 6/11/2020
Hand Sanitizer Guidance Extension Act of 2020 This bill specifies that certain Food and Drug Administration guidance related to the manufacture of alcohol-based hand sanitizers during the COVID-19 (i.e., coronavirus disease 2019) public health emergency shall remain in effect for two years after this bill's enactment. The bill also imposes various requirements related to the content of hand sanitizers manufactured while the guidance is in effect.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2934-2935; text: CR S2934)
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2934-2935; text: CR S2934)
Cardiovascular and respiratory healthDrug safety, medical device, and laboratory regulationEmergency medical services and trauma careHazardous wastes and toxic substancesHealth promotion and preventive careHealth technology, devices, suppliesInfectious and parasitic diseasesManufacturingMotor fuels